Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Thum

Showing results (51-60 of 500) with videos related to

Pageof 50
Sort By:
European Heart Journal|November 12, 2019
Living myocardial slices: a novel multicellular model for cardiac translational researchFilippo Perbellini, Thomas Thum
Annual Review of Pharmacology and Toxicology|October 12, 2013
microRNA therapeutics in cardiovascular disease modelsSeema Dangwal, Thomas Thum
Circulation|March 12, 2008
Letter by Thum et al regarding article, "Oxidant stress impairs in vivo reendothelialization capacity of endothelial progenitor cells from patients with type 2 diabetes mellitus: restoration by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone"Thomas Thum, Johann Bauersachs
Circulation Research|April 26, 2014
LINCing MALAT1 and angiogenesisThomas Thum, Jan Fiedler
Nature Reviews. Cardiology|June 13, 2019
RNA-based diagnostic and therapeutic strategies for cardiovascular diseaseDongchao Lu, Thomas Thum
JACC. Basic to Translational Science|January 11, 2024
Development of a Mechanism-Based Next-Generation Therapeutic for Heart Failure Derived From the Dark GenomeJanika Viereck, Thomas Thum
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 14, 2020
Pharmacokinetics and Proceedings in Clinical Application of Nucleic Acid TherapeuticsMarkus Herkt, Thomas Thum
JACC. Basic to Translational Science|June 2, 2020
TGF-β Inhibitor CILP as a Novel Biomarker for Cardiac FibrosisSonja Groß, Thomas Thum
European Heart Journal|June 17, 2005
Mobilization of bone marrow-derived stem cells after myocardial infarction and left ventricular function: simply effects of optimized drug treatment?Thomas Thum, Johann Bauersachs
Cardiovascular Research|October 3, 2006
Sports or statins for atheroprotection? New insight from Kruppel-like factor 2Thomas Thum, Johann Bauersachs
Pageof 50

Showing results (51-60 of 500) with videos related to

Sort By:
Pageof 50
European Heart Journal|November 12, 2019
Living myocardial slices: a novel multicellular model for cardiac translational researchFilippo Perbellini, Thomas Thum
Annual Review of Pharmacology and Toxicology|October 12, 2013
microRNA therapeutics in cardiovascular disease modelsSeema Dangwal, Thomas Thum
Circulation|March 12, 2008
Letter by Thum et al regarding article, "Oxidant stress impairs in vivo reendothelialization capacity of endothelial progenitor cells from patients with type 2 diabetes mellitus: restoration by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone"Thomas Thum, Johann Bauersachs
Circulation Research|April 26, 2014
LINCing MALAT1 and angiogenesisThomas Thum, Jan Fiedler
Nature Reviews. Cardiology|June 13, 2019
RNA-based diagnostic and therapeutic strategies for cardiovascular diseaseDongchao Lu, Thomas Thum
JACC. Basic to Translational Science|January 11, 2024
Development of a Mechanism-Based Next-Generation Therapeutic for Heart Failure Derived From the Dark GenomeJanika Viereck, Thomas Thum
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 14, 2020
Pharmacokinetics and Proceedings in Clinical Application of Nucleic Acid TherapeuticsMarkus Herkt, Thomas Thum
JACC. Basic to Translational Science|June 2, 2020
TGF-β Inhibitor CILP as a Novel Biomarker for Cardiac FibrosisSonja Groß, Thomas Thum
European Heart Journal|June 17, 2005
Mobilization of bone marrow-derived stem cells after myocardial infarction and left ventricular function: simply effects of optimized drug treatment?Thomas Thum, Johann Bauersachs
Cardiovascular Research|October 3, 2006
Sports or statins for atheroprotection? New insight from Kruppel-like factor 2Thomas Thum, Johann Bauersachs
Pageof 50